MPLT: Is the IPO working according to a scenario

After the IPO, the stock is forming a falling wedge — a classic post-listing accumulation pattern. Price is consolidating between the 15.03 support level and the accumulation zone. We see a trendline breakout attempt and price trying to hold above. The key resistance is 19.01, aligning with the previous consolidation range. Lowering volume indicates seller exhaustion. Scenario: breakout above 16.20 and confirmation gives a path toward target 1 at 19.01, with a potential impulse toward 22.50 (target 2). Entry only after breakout + retest. Without a retest, the risk of a fake breakout increases.

MPLT is a biotech company newly listed on NASDAQ. Post-IPO stocks often go through correction and accumulation while the market defines fair value. FDA updates or clinical trial results can act as catalysts — biotech names tend to move aggressively on news. If institutional interest increases, the trend may accelerate quickly.

If the breakout confirms — the rocket won’t wait for you to fasten your seatbelt. Let price show direction instead of forcing an entry inside noise.